Once the period for applications submission is finished, all the documentation provided has been reviewed and the list for funded EoI is approved.
The Assessment Committee, met on October 8th, in accordance with the criteria described in the call, has evaluated the Collaborative Projects and has raised a list of proposals selected to be funded.
Therefore, I resolve to,
- Grant the Collaborative Projects detailed in Table 1.
- Notify this resolution to the Collaborative Projects’ coordinator entity and publish it on CMR[B] and IDIBELL websites.
This funding will be compatible with any other one received for the same purpose, coming from any public or private, national or international funding body.
Barcelona, 25th November 2019.
Ángel Raya Chamorro
Director of the Centre for Regenerative Medicine of Barcelona (CMR[B])
Gabriel Capellá i Munar
Director of the Bellvitge Biomedical Research Institute (IDIBELL)
PROJECTS, IPs AND BUDGETS:
–New neurovascular remodelling strategies for neurorepair after stroke: from nanomedicine to neurorehabilitation therapies.
Anna Rosell Novell. Vall d’Hebron Institute of Research (VHIR). 10.000 €
–Blood cell regeneration from pluripotent stem cells.
Anna Bigas Salvans. Fundació Institut Mar d’Investigacions Mèdiques (IMIM). 10.000 €
–Cardiac engineered tissues for myocardial infarction: from pre-clinical validation to clinical translation.
Carolina Gálvez-Montón. Germans Trias i Pujol Health Science Research Institute (IGTP). 10.000 €
–Regenerating aged kidney function by targeting Cdc42 and senescent cells in human renal parietal epithelial cells (PECs).
Anna Sola Martínez. Bellvitge Biomedical Research Institute (IDIBELL). 10.000 €
–Transplantation of human iPS cells-derived RPE cell suspension for Age Related Macular Degeneration (AMD). First-in man clinical trial.
Anna Veiga Lluch. Bellvitge Biomedical Research Institute (IDIBELL). 10.000 €
–Culture, expansion and differentiation of human pancreatic organoids in a 3D hydrogel-based platform using selfassembling peptide nanofibers functionalized with instructive peptides.
Eduard Montanya Mias. Bellvitge Biomedical Research Institute (IDIBELL). 10.000 €
–Pharmacological stabilization of therapeutically-useful stem cells.
Biola María Javierre Martínez. Germans Trias i Pujol Health Science Research Institute (IGTP). 10.000 €
–Identification of molecular drivers of phenotypic variability in X-ALD by iPSc-derived brain organoid models.
Aurora Pujol Onofre. Bellvitge Biomedical Research Institute (IDIBELL). 10.000 €